<img id="00000000000000061901" src="/fileDownload2?fileGubun=phm&fileId=00000000000000061901" alt="" /> <table border="1" cellspacing="0" cellpadding="0" bordercolor="#ffffff"> <tbody> <tr> <td> <p><a href="http://info.evaluategroup.com/ep-wp2014-lp-ep.html" target="blank"><img style="border: black 1px solid;" src="http://www.evaluategroup.com/images/marketing/EvaluatePharma-World-Preview-2014-Outlook-to-2020-Cover.jpg" border="0" alt="EvaluatePharma World Preview 2013 - Outlook to 2018 " align="absMiddle" /></a></p> </td> <td> <p> <a href="http://info.evaluategroup.com/ep-wp2014-lp-ep.html" target="blank"><strong>Download EvaluatePharma World Preview 2014 Outlook to 2020</strong></a></p> <p>The seventh edition of EvaluatePharma's World Preview brings together many of our analyses to provide a top level insight, from the world's financial markets, into the expected performance of the industry between now and 2020.</p> </td> </tr> </tbody> </table> <p>Record breaking new drug approvals, a hefty product pipeline and dramatically improved R&D that has kept expenditure growth below sales growth proves that the industry is turning a new corner according to the latest edition of EvaluatePharma's World Preview report - <a href="http://www.evaluategroup.com/PDFs%20for%20Download/EvaluatePharma-World-Preview-2014-Outlook-to-2020-Infographic.pdf" target="blank">view infographic here (PDF)</a>. </p> <p><a href="http://www.burrillreport.com/content/podcast/CUT_SPM_BRP-7-7-14.mp3" target="blank"><strong>THE BURRILL REPORT PODCAST: Listen to Anthony Raeside, Head of Research at Evaluate, discussing World Preview 2014 at BIO 2014. </strong></a></p> <strong>Key highlights in EvaluatePharma's World Preview 2014, Outlook to 2020 include:</strong> <p> </p> <ul> <li>Industry to grow, on average, 5.1% per year from 2013 to 2020 </li> <li><strong>Quality of new drug approvals rose 43%, adds $24.4bn to US drug sales in 2018 </strong></li> <li>Biologicals make up 52% of top 100 prescription & OTC drug sales in 2020 </li> <li><strong>Oncology to set record high growth with 11.2% CAGR to 2020</strong> </li> <li>Novartis top company by global drug sales in 2013, expected to remain through 2020 </li> <li><strong>Teva Pharmaceutical leading generic drug maker in 2013</strong></li> </ul> <p><a href="http://info.evaluategroup.com/ep-wp2014-lp-ep.html" target="blank"><strong>Download EvaluatePharma World Preview 2014 Outlook to 2020</strong></a></p> <p><a href="http://www.evaluategroup.com/PDFs%20for%20Download/EvaluatePharma-World-Preview-2014-Outlook-to-2020-Executive-Summary.pdf" target="blank">Report Executive Summary</a></p>
소스입니다. Ctrl+C를 눌러 클립보드로 복사하세요

닫기